About MidAtlantic Fund
MidAtlantic Fund is a venture capital firm founded in 1999. It is primarily based out of New York City, United States. As of Nov 2005, MidAtlantic Fund has invested in 14 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Enterprise Infrastructure and Life Sciences. Most recently it participated in the $***** Series D round of NexTone Communications Overall, MidAtlantic Fund portfolio has seen 1 IPO and 6 acquisitions including key companies like Teladoc Health, Vertos Medical and Acton Pharmaceuticals. A lot of funds co-invest with MidAtlantic Fund, with names like Blue Rock Capital sharing a substantial percentage of its portfolio. MidAtlantic Fund has team of 7 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Portfolio IPOs
Portfolio Acquisitions
MidAtlantic Fund's List of Top Investments
MidAtlantic Fund has a portfolio of 14 companies. Their most notable investmentis in Netilla NetworksTheir portfolio spans across United States, China and India. They have invested in Enterprise Applications, Enterprise Infrastructure, Life Sciences and 4 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of top investments by MidAtlantic Fund:
Provider of telehealth and telemedicine services. It offers virtual care across various specialties, including mental health, weight management, diabetes management, hypertension management, dermatology, and primary care. The platform facilitates virtual consultations with physicians and therapists, providing convenient access to healthcare. Services are available for individuals and organizations, including employers, health plans, and hospitals. The company aims to improve access to quality healthcare through technology.
Key facts about Teladoc Health
- Founded Year: 2002
- Location: Purchase (United States)
- Annual Revenue: $2.57B as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $104M
- Employee Count: 5,500 as on Dec 31, 2024
- Investors: Scheuermann Investment, Icon Ventures and 26 Others
- Latest Funding Round: Post IPO, May 14, 2020, $*****
- Highlight: Public
Developer of minimally invasive treatment for lumbar spinal stenosis. The company uses Mild its proprietary technology, which is an image-guided outpatient procedure that removes a major root cause of LSS through an incision smaller than the size of baby aspirin and doesn’t require implants, general anesthesia, or stitches.
Key facts about Vertos Medical
- Founded Year: 2005
- Location: Aliso Viejo (United States)
- Stage: Acquired
- Total Funding till date: $178M
- Employee Count: 137 as on Jul 01, 2024
- Investors: SVB Securities, Norwest and 9 Others
- Latest Funding Round: Series F, Jun 06, 2023, $*****
- Highlight: Acquired
Acton Pharmaceuticals is developing and commercializing products primarily for the treatment of respiratory conditions. It was acquired by Meda Pharmaceuticals on August 30, 2013.
Key facts about Acton Pharmaceuticals
- Founded Year: 2008
- Location: Marlborough (United States)
- Stage: Acquired
- Total Funding till date: $36.7M
- Employee Count: 6 as on Jul 01, 2024
- Investors: Sequoia Capital and MidAtlantic Fund
- Latest Funding Round: Series B, May 13, 2013, $*****
- Highlight: Acquired
NexTone communications is a software-centric session border controller (SBC) and session management provider for IP-based services (like VOIP). Its services include service connectivity, quality of service, traffic management, and policy enforcement. Its iServer architecture enables rapid design and deployment of services and value-added applications to small and medium-sized businesses. Develops carrier-grade products for delivering scalable control of real-time IP services, such as VoIP. Solutions enable carriers, service providers, and enterprises to interconnect networks for end-to-end control and management of IP traffic. Merged with Reef point in 2007 to form NextPoint Communications.
Key facts about NexTone Communications
- Founded Year: 1998
- Location: Bengaluru (India)
- Stage: Acqui-Hired
- Total Funding till date: $92.5M
- Investors: Columbia Partners, MidAtlantic Fund and 6 Others
- Latest Funding Round: Series E, Sep 12, 2006, $*****
Straighter teeth and healthier smiles through aligners, braces, and retainers. They offer teeth straightening treatments designed for individual needs, supported by doctors. The company provides a range of options, including clear, removable aligners, and digitally designed braces. Treatment plans are customized, and payment/financing options are available. They focus on comfort, convenience, and personalized care throughout the teeth-straightening journey. They leverage digital technology and expert dental professionals to deliver effective teeth alignment solutions. They are backed by a large dental product manufacturer, ensuring quality and reliability. The company is focused on improving oral health and aesthetics.
Key facts about Propel Orthodontics
- Founded Year: 2010
- Location: Ossining (United States)
- Stage: Acquired
- Employee Count: 3,564 as on Dec 31, 2022
- Investors: MidAtlantic Fund
- Highlight: Acquired
MidAtlantic Fund's Investments by Stage
MidAtlantic Fund has made 1 investment in Series A stage with an average round size of $2M, 1 investment in Series B stage with an average round size of $6.8M, 1 investment in Series C stage with an average round size of $6M and 1 investment in Series D stage with an average round size of $35M.Stage of entry | No. of Investments |
|---|---|
Series A | 1 |
Series B | 1 |
Series C | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
MidAtlantic Fund's Investments by Sector
MidAtlantic Fund has a diverse portfolio, with companies operating in the Enterprise Applications, Enterprise Infrastructure, Telecom and HealthTech. Notably, it has invested in 9 Enterprise (B2B) companies, 9 Tech companies, 5 Software companies and at least 1 company focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
Enterprise Infrastructure | 2 |
Telecom | 2 |
HealthTech | 1 |
Note: We have considered here, only first round of investments
MidAtlantic Fund's Investments by Geography
MidAtlantic Fund has made most investments in United States (3), followed by India where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 3 |
India | 1 |
Note: We have considered here, only first round of investments
MidAtlantic Fund's recent investments
MidAtlantic Fund has not made any investment in 2026 so far.Here are the most recent investments by MidAtlantic Fund:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 07, 2005 | India | Series D | 1229 | [+1] | |
Nov 2005 | United States | Series D | 8506 | ||
Aug 09, 2005 | United States | Series C | 9707 | [+2] | |
Jun 10, 2004 | United States | Series B | 2167 | [+2] | |
Mar 23, 1999 | India | Series A | 3975 |
IPOs and Publicly Listed companies in MidAtlantic Fund's Portfolio
1 of MidAtlantic Fund's portfolio company became public - Teladoc Health. It got listed on the New York Stock Exchange (NYSE), in Jul 2015 at marketcap of $704MHere are MidAtlantic Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 01, 2015 | - | - | 6400 |
Acquired companies in MidAtlantic Fund's Portfolio
6 companies from MidAtlantic Fund's portfolio have been acquired. The most recent acquisition were Vertos Medical in Aug 2024 by Stryker.Here are MidAtlantic Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 22, 2024 | - | - | 5787 | |
Jun 04, 2021 | - | - | 3684 | |
Aug 30, 2013 | - | - | 7439 | |
Oct 14, 2008 | Jun 10, 2004 | Series B | 6682 | |
Sep 16, 2008 | Mar 23, 1999 | Series A | 8079 |
Team profile of MidAtlantic Fund
MidAtlantic Fund has a team of 7 members including 4 Partners and 1 Principal located in United States. MidAtlantic Fund's team does not sit on the board of any company as of now.Here is a list of all team members in MidAtlantic Fund:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | ||
Partner | North Miami Beach | - | ||
Partner | - | - | - | |
Partner | - | - | - | |
Principal | - | - |
Co-investors of MidAtlantic Fund
Over the past 27 years, 17 investors have co-invested in MidAtlantic Fund's portfolio companies. This includes only funds.
- Invested before MidAtlantic Fund: Ascend Venture Group, Mid-Atlantic Venture Funds and 2 others have invested in rounds before MidAtlantic Fund. There is 1 company where Ascend Venture Group has invested before MidAtlantic Fund and 1 company where Mid-Atlantic Venture Funds has invested before MidAtlantic Fund.
- Top Co-investors of MidAtlantic Fund: 9 investors entered a company along with MidAtlantic Fund. These include investors like Blue Rock Capital (1 company).
- Invested after MidAtlantic Fund: A total of 4 investors have invested in MidAtlantic Fund's portfolio after their investments. Top Investors include One Equity Partners (1 company), Core Capital Partners (1 company) and Safeguard Scientifics (1 company).
Recent News related to MidAtlantic Fund
•
Softrax receives additional $10M in fundingThe Business Journals•Jun 27, 2000•SOFTRAX, Allegra Capital, Egan-Managed Capital, Knickerbocker and 3 others
